Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: A multicenter, randomized phase III trial (SOS)

on behalf of the SOS study investigators

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)

Fingerprint Dive into the research topics of 'Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: A multicenter, randomized phase III trial (SOS)'. Together they form a unique fingerprint.

Medicine & Life Sciences